TY  - GEN
AU  - Yano,Masafumi
AU  - Okuda,Shinichi
AU  - Oda,Tetsuro
AU  - Tokuhisa,Takahiro
AU  - Tateishi,Hiroki
AU  - Mochizuki,Mamoru
AU  - Noma,Toshiyuki
AU  - Doi,Masahiro
AU  - Kobayashi,Shigeki
AU  - Yamamoto,Takeshi
AU  - Ikeda,Yasuhiro
AU  - Ohkusa,Tomoko
AU  - Ikemoto,Noriaki
AU  - Matsuzaki,Masunori
TI  - Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure
SN  - 1524-4539
PY  - 2006///0222
KW  - Animals
KW  - Antioxidants
KW  - pharmacology
KW  - Antipyrine
KW  - analogs & derivatives
KW  - Calcium
KW  - metabolism
KW  - Cardiac Pacing, Artificial
KW  - Dogs
KW  - Edaravone
KW  - Heart Failure
KW  - drug therapy
KW  - Heart Ventricles
KW  - Muscle Cells
KW  - cytology
KW  - Nitric Oxide Donors
KW  - Oxidative Stress
KW  - drug effects
KW  - Protein Structure, Tertiary
KW  - Ryanodine Receptor Calcium Release Channel
KW  - chemistry
KW  - Sarcoplasmic Reticulum
KW  - Tacrolimus Binding Protein 1A
KW  - Treatment Outcome
KW  - Ventricular Remodeling
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/CIRCULATIONAHA.105.555623
ER  -